Publication | Open Access
Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells
44
Citations
18
References
2017
Year
Sali-NP-HER2 represents a promising approach in treating HER2-positive breast cancer by targeting both breast CSCs and cancer cells.
| Year | Citations | |
|---|---|---|
Page 1
Page 1